Melissa Johnson, MD

Trials

Studies that name Melissa Johnson, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:56 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06773910 · BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

  SCRI Development Innovations, LLC · active not recruiting · Limited Stage Small Cell Lung Cancer · study chair
• Ph2
  NCT05948462 · Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

  SCRI Development Innovations, LLC · withdrawn · Lung Cancer, Non-small Cell Lung Cancer · study chair
• Ph1/Ph2
  NCT05127590 · RBN-2397 in Combination With Pembrolizumab in Patients With SCCL

  Ribon Therapeutics, Inc. · unknown · Advanced Squamous Non-Small Cell Lung Carcinoma · principal investigator
• N/A
  NCT04976803 · Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

  Artios Pharma Ltd · completed · Solid Tumor, Unspecified, Adult · study chair
• Ph1/Ph2
  NCT04657068 · A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  Artios Pharma Ltd · recruiting · Advanced Cancer, Metastatic Cancer, Ovarian Cancer · study chair
• Ph1
  NCT04609579 · Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

  Stingthera, Inc. · terminated · Advanced Solid Tumor, Advanced Lymphoma · study chair
• Ph2
  NCT03977467 · Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

  SCRI Development Innovations, LLC · completed · Non-Small Cell Lung Cancer, Solid Tumor · study chair
• Ph1
  NCT02649673 · LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

  SCRI Development Innovations, LLC · terminated · Small Cell Lung Cancer, Ovarian Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.